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Background and Purpose: Over 30 million people in the United States (U.S.) have diabetes 
mellitus, which comprises about 9% of the population, and about 90% of individuals with 
diabetes have type 2 diabetes (Centers for Disease Control and Prevention [CDC], 2017).  Adults 
with type 2 diabetes at a local internal medicine clinic were consistently having high glycated 
hemoglobin (HbA1C) levels, demonstrated by data collected from the electronic health record 
(EHR), and there was no ordering process for referring patients to diabetes management 
education and support (DSMES) services.  The purpose of this project was to improve glycemic 
control, demonstrated by lower HbA1C levels, and reach a diabetes education attendance rate of 
62.5% at an internal medicine clinic in Chandler, Arizona. 
Methods: An electronic health record (EHR) template was created and brief staff training was 
completed to connect patients with diabetes in the community to a local formal diabetes 
education program.  HbA1C levels were measured before and three months after adults with type 
2 diabetes mellitus (T2DM) received physicians’ orders for a DSMES program, and rates of 
attendance to the program were calculated.  Data was collected through the EHR and through 
feedback from the DSMES program.  Descriptive statistics were used in data analysis.  
Outcomes: The participants’ results did not demonstrate significant differences in pre-referral 
and post-referral HbA1C results after they were ordered DSMES services (p = .506).  The 
proportion of education attendance (30%) was lower than the project goal of 62.5%, but 
increased from the clinic baseline.   
Conclusions: EHR template implementation for referral to DSMES may increase rates of formal 
diabetes education and improve glycemic control.  Larger sample sizes, longer project periods, 
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alternative methods of communication, and increased follow-up of participants may be required 
to produce significant results.  
Keywords: diabetes mellitus, HbA1C, glycated hemoglobin, group-based education, 




















DIABETES EDUCATION  4 
Improving Glycemic Control in Patients with Type 2 Diabetes through Formal Education 
Uncontrolled type 2 diabetes mellitus (T2DM) can cause avoidable consequences such as 
cerebrovascular accident (CVA), myocardial infarction (MI), renal failure, visual disturbance, 
amputation of extremities, and death. Over 30 million people in the U.S. have diabetes, and 
approximately 90% of them are affected by T2DM, which can be prevented, delayed, and treated 
with healthy lifestyle modifications, such as healthy eating, weight loss, and exercise (CDC, 
2017).  Adults with diabetes at a local internal medicine clinic were having HbA1C levels that 
were higher than the recommended level.  After synthesizing the evidence of potential effects of 
group-based education (GBE) on HbA1C levels and knowledge of disease (KOD), a project was 
initiated to implement a staff-training program and an EHR template, to connect patients with 
diabetes in the community to a local formal diabetic education program. 
Background & Significance 
Healthy People 2020 sets national goals to improve the outcomes for patients with 
diabetes.  One of the high-priority objectives is to decrease the number of patients with diabetes 
who have HbA1C levels greater than 9% (Office of Disease Prevention and Health Promotion 
[ODPHP], 2014).  The organization has also set the goal for the number of patients receiving 
formal diabetes education at 62.5%; this would be approximately 10% improvement from 
current trends.  This project aligns with national goals to improve glycemic control by decreasing 
HbA1C levels in patients with T2DM at a local internal medicine clinic and strives to achieve a 
62.5% rate of patients receiving formal diabetes education. 
Quality improvement (QI) efforts by national organizations have spurred the creation of 
measurement tools in the EHR. These tools allow providers to measure their patients’ progress in 
major national health initiatives. One component of the system at a local internal medicine clinic 
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displays patients with a diagnosis code for diabetes, between 18 and 75 years of age, who have 
an HbA1C level greater than 9, indicating poor disease control.  Two hundred and forty patients 
met the criteria in that age range at Lifeline Internal Medicine.  According to this quality 
indicator, approximately 60% of the 240 patients had poorly controlled diabetes.  This indicates 
over one half of their patient population in that age range had blood glucose levels that were 
consistently at dangerous levels, putting them at risk for serious complications.   
Soft data gathered from the staff at this internal medicine clinic echoed the statistic 
generated from their EHR.  They expressed concern for a large portion of their patient 
population, which was not attaining adequate control of their diabetic disease processes.  In 
addition to high HbA1C levels, the staff has witnessed several other trends in their patients with 
diabetes, which may be contributing to the lack of glycemic control.  The patients presented to 
follow-up appointments without logs of their daily blood glucoses that the provider had 
requested, without knowledge pertaining to their disease processes and treatment plan, and did 
not adhere to lifestyle modification recommendations. Furthermore, providers at the clinic were 
not referring patients for any type of formal diabetes education. This data suggested that an 
intervention to improve care of patients with T2DM would be beneficial for the clinic and led to 
the initiation of this project. 
The goals of this project were to lower HbA1C levels and increase rates of diabetes 
education attendance to decrease the risk of diabetic complications, improve patients’ health 
statuses, and reduce their future healthcare costs.  This led to the PICO question, “In adults with 
type 2 diabetes at Lifeline Internal Medicine, will formal group education, versus usual care, 
improve glycemic control?” 
Evidence Synthesis 
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An exhaustive search was conducted in the Cumulative Index of Nursing and Allied 
Health Literature (CINAHL), PubMed, and JSTOR databases.  Initial keywords in the search 
strategy were diabetic, diabetes, compliance, compliant, adherence, adherent, and adult with 
Boolean connectors. The keywords compliance, compliant, adherence, adult, and adherent were 
subsequently removed after the most promising, potential intervention became more apparent.  
The terms education, group, type 2, glycated hemoglobin, and knowledge were added as 
keywords. Additional filters included studies in the past five years, full text availability, and 
English language.  After the search process was complete, pertinent studies were synthesized to 
analyze current evidence related to the project goals. 
 Summaries of essential characteristics of the synthesized studies can be found in the 
Evaluation Table (Appendix A).  Many valid and reliable tools of measure were used for data 
collection, and bias could be considered minimal in most and moderate in a few of the studies.  
When referencing the Synthesis Table (Appendix B), the majority of the collected evidence can 
be recognized as Level II or III evidence, including primarily randomized controlled trials 
(RCTs).  One systematic review was included.  Only recent studies were included, with the 
oldest study published in 2013.  The number of participants ranged from 82 to 77,824.   
A diverse group of authoring countries was included in appraisal, evaluation, and 
synthesis of recent evidence. The synthesized components of the selected studies were focused 
areas examining interventions to improve glycemic control, measured by HbA1C, and increase 
KOD in patients with T2DM.  Two of the studies also examined the effect of GBE on medication 
adherence.  In all of the studies, the attrition rates were less than 50%, and 8 of the studies had 
attrition rates less than 30%.  Most studies included an intervention consisting of GBE, and few 
of the studies included complementary interventions, such as telephone calls, individual based 
DIABETES EDUCATION  7 
education (IBE) and home visits.  To address the population of the studies, only one study 
included patients with type 1 diabetes mellitus.  All other participants were patients with T2DM.  
As the resources spent on diabetic complications increase, researchers are working to 
identify low-cost interventions to improve glycemic control and health maintenance in patients 
with diabetes.  Scripted phone calls to patients in a large randomized trial did not significantly 
improve diabetic control compared to usual care (O’Connor et al., 2014).  However, group 
education has been an effective intervention, improving glycemic control more than home visits 
(Santos et al., 2017).  A research study in Brazil was conducted to evaluate patients with diabetes 
mellitus (DM) “before and after” an educational program.  The educational intervention 
significantly increased the participants’ KOD, while also improving HbA1C levels and 
adherence to their medication regimens (Figueira, Boas, Coelho, Freita, & Pace, 2016).   
 Patients’ attitudes toward their diabetes were investigated using questionnaires, revealing 
that many people with DM may not understand the HbA1C level, and may need simpler 
explanations of key diabetic concepts, with less medical jargon.  Overall, participants were 
trusting of their providers, but may be given insufficient or incorrect education by such 
providers.  Many patients revealed that they are using diabetic medication to avoid healthy 
lifestyle modifications (Elliott, Harris, & Laird, 2016). A cross-sectional study in St Louis, 
Missouri reported findings indicating most patients are unintentionally non-adherent to treatment 
plans, suggesting educational interventions may be helpful and should be designed for patients 
with limited health literacy (Fan, Lyons, Goodman, Blanchard, & Kaphingst, 2016).  
Patients newly diagnosed with diabetes are not the only group who could benefit from 
educational interventions.  If patients are not meeting their glycemic goals, educational 
reinforcement should be implemented, and patients with pre-diabetes may benefit from early 
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formal education.  However, the best method for such education and the route to making 
educational interventions more widely available are not yet clear (Beverly et al., 2013).  
 The synthesis of evidence reveals improved glycemic control and KOD in patients with 
T2DM that received educational interventions, particularly GBE.  With evaluation of the 
significant effects that the educational interventions had on HbA1C levels and KOD, the data 
suggests that patients with T2DM may benefit from GBE.  The evidence supports the use of 
GBE for patients with T2DM, but roughly half of the patients in Arizona are receiving proper 
diabetes self-management education (ODPHP, 2014). A sustainable intervention to improve rates 
of diabetic education is essential for the health of our patients and to reduce healthcare costs.    
By increasing availability of diabetes education programs to patients in a local internal 
medicine clinic, it was proposed that more of the clinic patients would receive formal diabetes 
education, decreasing their HbA1C levels.  The goal of this project was to increase the 
availability of formal diabetes self-management programs to patients and significantly affect 
their HbA1C, making it a low-cost, sustainable intervention to improve diabetic outcomes for 
this clinic.   
Theoretical Framework & Implementation Framework 
Theoretical Framework 
 The Chronic Care Model (Figure 1) was selected as the theoretical framework to support 
this project (Wagner, 1998).  In the Chronic Care Model, resources and policies from the 
community interact with health care organization to promote productive interactions between an 
informed, activated patient and a prepared, proactive practice team.  Inspiration from the self-
management support aspect of the Chronic Care Model spurred the desire to activate and inform 
patients with T2DM at Lifeline Internal Medicine.  This project also focused on the clinical 
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information systems aspect of the model, incorporating an additional innovative model, to prepare 
the practice team at the clinic for project implementation and create an EHR template that would 
streamline the project delivery. 
Implementation Framework 
Tidd and Bessant’s Process Model of Innovation (Figure 2) was chosen to apply the 
synthesis of evidence to current practice (Dawson & Andriopoulos, 2017).  This model is concise 
and allows for customization.  Four steps of the model were used to guide the project and 
intervention, displaying the rationale for the employees at the office and serving as a tool for 
potential barriers along the way.  The first step of the model is search and assessment.  In this 
step, the area needing improvement is identified.  At Lifeline Internal Medicine, the opportunity 
was identified as diabetes self-management.  The second step explores what the intervention will 
be and why it is being done. In this case, we wanted to improve glycemic control through GBE. 
The rationale for the intervention includes the soft data, including requests from patients and 
staff and is based on an ethical foundation. The third step includes implementation. Specifically, 
the staff received education regarding diabetes self-management programs, the new EHR 
template for ordering patient education, and network education options to improve the care of 
patients with diabetes. Participants’ HbA1C levels were measured pre- and post- GBE.  The final 
step of the framework captures the value in the innovation.   
Methods 
Human Subject Protection 
Internal Review Board (IRB) approval was granted through Arizona State University 
(ASU) prior to the initiation of this project.  All clinic staff members had access to the data of the 
project, through the password-protected EHR.  The team leader extracted lab values and relevant 
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information for the project through the EHR.  All paper information pertaining to the project was 
stored in a lockable bag. The project leader maintained a master list to link the name of the 
participant with a unique numerical study ID (participant 1, 2, 3, etc.,) and stored the master list 
in a lockable bag. All project information was kept confidential.  Only de-identified data was 
retained after data collection. The master list connecting data with the participants’ identities was 
destroyed at the end of data collection.  
As consent for this project was in the pre-existing new patient paperwork for the 
participants, the paperwork was stored electronically in the patients’ charts per clinic standard. 
All patients received and signed this paperwork prior to being treated at the clinic. No data was 
collected from the staff before or after staff training. There was no compensation or credit 
offered to staff or patients to participate in the project.  
 Testing a patient’s HbA1C requires a blood draw.  However, in this project, blood draws 
were ordered per usual care, and the patient did not require any additional lab work to what 
would have been ordered if the patient were not a participant in the project. The results that were 
delivered to the provider were accessed through the EHR.  No psychological or legal risks were 
foreseeable for patients who participated in the events and data collection involved with this 
project. 
By participating in the education, the participants learned about their disease and how to 
manage it.  This could improve their glycemic control, improve their quality of life, and decrease 
their risk of mortality. A large community-based population study included over 11,000 
participants and found that in the participants with diabetes, an increase of 1% in HbA1C 
concentration was associated with 40% increase in mortality from cardiovascular issues and 30% 
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increase in all-cause mortality (Sherwani, Khan, Ekhzaimy, Masood, & Sakharkar, 2016). A 
reduction in the HbA1C concentration of 0.2% could decrease the patient’s mortality by 10%. 
Population & Setting 
 This project took place at a local internal medicine clinic. The final study sample only 
included patients with T2DM. Although the incidence of diabetes diagnoses in children is 
increasing, only 0.18% of the U.S. population under 18 years old is diagnosed with diabetes 
(CDC, 2017).  This statistic sheds light on the population of interest, adults 18 years of age and 
older, diagnosed with T2DM. Participants were required to speak English.  Minors were 
excluded from the study, as this clinic does not treat pediatric patients. No other specific 
populations were targeted or excluded.  
Since HbA1C levels can be affected by alterations in hemoglobin and other blood-related 
alterations, HbA1C data from patients with a diagnosis code in their chart of anemia, end-stage 
renal failure, or recent (last 3 months) blood transfusion were excluded from the analysis. 
However, they were not excluded from referral to the education program, and their participation 
was included when measuring the percentage of patients who completed the formal diabetes 
education program.  Participants needed a recent (6 months or less) HbA1C level to be included 
in the project. 
Project Description & Timeline 
Practice and systematic changes were implemented to improve (increase) rates of formal 
diabetes education and improve (decrease) HbA1C levels in patients with T2DM at Lifeline 
Internal Medicine Clinic.  A template was created in the existing EHR program to streamline the 
process of ordering group-based diabetes management education for patients who might benefit 
from formal diabetes education.  Patients were referred to a local, established DSMES program, 
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which is recognized by the American Diabetes Association (ADA), to promote potential 
insurance coverage and limit or abolish costs to patients.   
Brief staff training was conducted for the staff members of Lifeline Internal Medicine to 
inform them of an available community diabetes educational resource and how to order DSMES 
for eligible patients using the new EHR fax template.  The training was less than twenty minutes 
and was scheduled when minimal patient appointments were scheduled. Each member of the 
team was addressed individually to make sure he or she did not have any further questions and 
all components of the project were clear.  
The first outcome that was measured in this project was the HbA1C level of each 
participant.  Upon entering the bloodstream, glucose binds to hemoglobin in red blood cells.  The 
HbA1C level represents the percentage of red blood cells, containing hemoglobin that is coated 
in glucose. HbA1C level over 6.5% indicates diabetes.  The standard goal for the HbA1C level is 
less than 7% (CDC, 2018). The World Health Organization (WHO) recognizes the HbA1C level 
as diagnostic for diabetes (Florkowski, 2013).  National organizations, such as those overseeing 
government insurances and diabetic guidelines, have focused on the HbA1C level as a reliable 
measure of diabetic control. The HbA1C level was measured using a blood sample.  The patient 
did not need to fast for the test, and it is routinely checked every 3 months in most patients with 
T2DM at Lifeline Internal Medicine. HbA1C levels of the patients referred by the clinic were 
measured prior to the referral for education, as this criterion is pertinent for the provider’s 
consideration to refer the patient for education and for insurance coverage processes. Pre-
intervention HbA1C levels were already on file, as they are used for the initial diabetes diagnosis 
and are monitored at regular quarterly intervals.  
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Once glucose binds to hemoglobin in the blood stream, it is attached permanently until 
the red blood cell dies.  The average lifespan of a red blood cell is approximately 3-4 months, so 
this was the ideal time for their second blood draw.  Since exact dates for lab draws and program 
activities were not the same for every patient, HbA1C levels collected in a timeframe of 2-4 
months post-referral to the education program were allowed for inclusion in the data analysis.  
HbA1C levels as early as 2 months post-referral date were included, since HbA1C is based on 
weighted monthly averages.  50% of the HbA1C concentration is formed from glycaemia in the 
most recent month (Florkowski, 2013).  25% is formed in the month prior to that, and the final 
25% is formed in the month before that. There is not a phlebotomist at the clinic, so per usual 
care, the patients were given an order from the provider for the tests, and they had samples 
drawn at their regular laboratory.  Variability in lab sites could have affected HbA1C results.  
Variability in blood draw locations was considered an accepted risk for the project to be 
sustainable, and so unnecessary inconvenience was not created for the patient.  
Additionally, the project evaluated whether training the staff on the community resource 
for diabetes education increased the number of patients receiving formal diabetes education.  The 
goal of this project will align with Healthy People 2020’s goal of 62.5% participation in formal 
diabetes education (ODPHP, 2014).  Patients were referred to the nearest diabetes self-
management education program at Mercy Gilbert Medical Center.  Materials and education 
distributed at the program were independent of this project. If patients attended one or more 
hours of education, they were counted in the group that attended the education program.  Follow-
up consisted of usual care and two follow-up phone calls to remind patients to have their lab 
work completed. 
Data Collection & Analysis 
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After the staff training, data collection began to track the patients who were referred to 
the community education program and the patients who attended the program.  This was done by 
searching the EHR for electronic fax referrals sent from the start date of recruitment through 
October 31, 2019. All information was gathered through the EHR.  Contact with the diabetes 
education program to determine whether or not the patient completed the educational program 
closed the loop.  The ratio of participants who attended the program to number of participants 
who were referred was essential to the data analysis and conclusion portions of the project.  The 
project attendance percentage was compared to the national goal percentage of 62.5%.  
Budget 
The proposed budget total for this project was $301.85 (Appendix E). Sources of funding 
for the project included personal funds and clinic funds.  Clinic funds accounted for the 
productivity lost, and paper copies and equipment were purchased using personal funds.  Other 
non-calculated costs included the cost of the education to patients, if their insurance did not 
cover the entire program.  Efforts by the provider and community program were made to make 
sure the patient receives coverage for the services, if they were eligible.  Since the local DSMES 
program provided pamphlets, the expense for printing pamphlets was avoided.  Expenses for a 
locking receptacle for project materials were decreased by purchasing a lock for a container the 
project leader already had available for use.  
Project Impact  
 On a local level, the patients, physicians, and staff at Lifeline Internal Medicine had 
stakes in the success of this project.  If the intervention was successful in improving glycemic 
control, it could improve outcomes, decrease costs and complications, free up providers’ time, 
and increase productivity in the workplace and the community. In the future, the results of this 
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project may be applicable when discussing potential interventions for patients who present with 
pre-diabetes, as well.  In 2015, 33.9% of adults, and nearly half of the population above 65 years 
of age, had pre-diabetes (CDC, 2018). 
In the state of Arizona, in 2010, only 51.4% of patients with diabetes received education 
regarding the disease process (ODPHP, 2014).  By educating the staff on community resources 
available to their patients and increasing availability of diabetes education programs to patients 
in a local internal medicine clinic, it was proposed that more of the clinic patients would receive 
formal diabetes education, decreasing their HbA1C levels.  If the training program increased the 
availability of formal diabetes self-management programs to patients or significantly affected 
their HbA1C, it would be a low-cost, sustainable intervention to improve diabetic outcomes for 
this clinic.  This could lead to initiation of cost-effective strategies to decrease complications and 
healthcare costs from diabetes.   
 T2DM complications exhaust resources and contribute to significant healthcare costs 
globally. The cost of care for DM in the U.S. is $327 billion per year (ADA, 2018). The majority 
of the money is used for inpatient hospital care and prescriptions to treat complications of the 
disease.  The majority of T2DM care in the U.S. is paid for by government insurances, such as 
Medicare, Medicaid, and the military (ADA, 2018).  
In 2014, more money was spent on DM discharges than any other emergency department 
visit or hospital stay in Arizona (Arizona Department of Health Services [AZDHS], 2018). Over 
$8 million dollars was charged for DM for those hospital visits, more than six times the amount 
charged for CVA.  Results of this project will contribute to the knowledge that could guide 
interventions to decrease complications of diabetes, increase rates of diabetes education, and 
decrease costs of care in patients with T2DM.   
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Results 
Descriptive statistics were used to describe the sample and outcome variables. The 
physicians at an internal medicine clinic in Chandler, Arizona ordered DSMES services through 
the created EHR template for 10 patients during the recruitment period.  The sample consisted of 
10 participants (N=10).  Twenty percent of participants who were referred for the DSMES 
program completed the 10-hour educational program. Ten percent of participants completed at 
least 1 hour of the educational program.  Thirty percent of participants who were referred 
declined the program, 30% did not respond to two or more attempts at contact, and 10% of 
participants no-showed to the scheduled program.   
The average age of the subjects was 61.10 (SD = 8.96).  Ages ranged from 45 to 74 years.  
Each gender had an observed frequency of 5 (50%).  Frequencies and percentages for insurance, 
race, and gender are presented in Table 1. 
Table 1 
Frequency Table for Gender, Race, and Insurance 
Variable n % 
Gender     
    1 5 50 
    2 5 50 
    Missing 0 0 
Race     
    1 3 30 
    2 1 10 
    3 3 30 
    5 3 30 
    Missing 0 0 
Insurance     
    1 3 30 
    2 1 10 
    3 6 60 
    Missing 0 0 
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The observations for pre-referral HbA1C in the group that did not attend the DSMES 
program had an average of 9.56% (SD = 2.24).  The observations for post-referral HbA1C in the 
group that did not attend the DSMES program had an average of 7.83% (SD = 1.00).  The 
summary statistics can be found in Table 2. 
Table 2 
Summary Statistics Table for Pre- and Post-Referral HbA1C Variables in Participants who Did 
Not Attend Education 
Variable M SD n SEM Min Max Skewness Kurtosis 
Post_HbA1C 7.83 1.00 3 0.58 6.70 8.60 -0.58 -1.50 
Pre_HbA1C 9.56 2.24 7 0.85 7.00 12.90 0.38 -1.15 
Note. '-' denotes the sample size is too small to calculate statistic. 
The observations for pre-referral HbA1C in the group that attended the DSMES program 
had an average of 8.63 (SD = 2.42).  There were insufficient observations to calculate summary 
statistics for post-referral HbA1C. The summary statistics can be found in Table 3. 
Table 3 
Summary Statistics Table for Pre- and Post-Referral HbA1C Variables in Participants who 
Attended Education 
Variable M SD n SEM Min Max Skewness Kurtosis 
Post_HbA1C 7.70 - 1 - 7.70 7.70 - - 
Pre_HbA1C 8.63 2.42 3 1.40 6.90 11.40 0.64 -1.50 
Note. '-' denotes the sample size is too small to calculate statistic. 
A two-tailed paired samples t-test was conducted to examine whether the mean difference 
of pre-referral HbA1C and post-referral HbA1C results from the group that did not attend the 
education program were significantly different from zero.  The result of the two-tailed paired 
samples t-test was not significant based on an alpha value of 0.05, t(6) = 2.22, p = .068, 
indicating the null hypothesis cannot be rejected. The results are presented in Table 4.  
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Table 4 
Two-Tailed Paired Samples t-Test for the Difference between Pre-Referral HbA1C and Post-
Referral HbA1C in the Group that Did Not Attend Education 
Pre_A1C Post_A1C_imputed       
M SD M SD t p d 
9.56 2.24 7.88 0.90 2.22 .068 0.84 
Note. N = 7. Degrees of Freedom for the t-statistic = 6. d represents Cohen's d. 
A two-tailed paired samples t-test was conducted to examine whether the mean difference 
of pre-referral HbA1C and post-referral HbA1C results was significantly different from zero in 
the group that attended the education program.  The result of the two-tailed paired samples t-test 
was not significant based on an alpha value of 0.05, t(2) = 0.90, p = .465, indicating the null 
hypothesis cannot be rejected. The results are presented in Table 5. 
Table 5 
Two-Tailed Paired Samples t-Test for the Difference Between Pre-Referral HbA1C and Post-
Referral HbA1C in Group that Attended Education Program 
Pre_A1C Post_A1C_imputed       
M SD M SD t p d 
8.63 2.42 7.49 0.34 0.90 .465 0.52 
Note. N = 3. Degrees of Freedom for the t-statistic = 2. d represents Cohen's d. 
Effect of Group Education on HbA1C  
A mixed model analysis of variance (ANOVA) with one within-subjects factor and one 
between-subjects factor was conducted to determine whether significant differences exist among 
pre-referral HbA1C and post-referral HbA1C between the group that attended the educational 
program and the group that did not attend the educational program, using imputed values for 
post-referral HbA1C missing values. The results were examined based on an alpha of 0.05. The 
main effect for education was not significant F(1, 8) = 0.48, p = .506, indicating the two 
education groups were similar. The main effect for the within-subjects factor was not 
significant F(1, 8) = 3.96, p = .082, indicating the values of pre-referral HbA1C and post-referral 
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HbA1C were all similar. The interaction effect between the within-subjects factor and education 
was not significant F(1, 8) = 0.14, p = .719, indicating that for all combinations of the within-
subjects factor and the education groups, the strength of the relationship between the outcome 
and the interaction of education does not change significantly.  
Comparison of Program Attendance to Goal 
A one-proportion z-test was conducted to examine whether education attendance could 
have been produced by a probability distribution with a proportion of 0.625. The result of the one 
proportion z-test was significant based on an alpha value of 0.05, z = -2.12, p = .034, CI = [-0.63, 
-0.02], indicating the null hypothesis can be rejected. This suggests that education attendance is 
unlikely to have been produced by a distribution with a proportion of 0.625. The proportion of 
education attendance is most likely lower than 0.625. The confidence interval (α = 0.05) for 
the proportions of education attendance is -0.63 to -0.02. Table 6 presents the results of the one 
sample proportion z-test. 
Table 6 
One Proportion z-Test for Education Attendance and a Test Proportion of 0.625 
Samples Responses n Proportion SD SE 
Education Attendance 3 10 0.3 0.46 0.15 
Note. z = -2.12, p = .034, CI for α = 0.05: [-0.63, -0.02]. 
Discussion 
 Although the results were not considered significant after data analysis, when considering 
limitations, this project reinforces the findings of other studies that GBE may improve 
knowledge of disease and HbA1C levels in patients with T2DM. As other studies pointed out, 
the best method for such education and the route to making educational interventions more 
widely available are not yet clear (Beverly et al., 2013). 
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Limitations 
 The sample size was a limitation of the project, which was evident in the data analysis 
portion of the project.  Since there were several missing values for post-referral HbA1C 
observations, missing values in both groups were imputed, since there were not at least three 
values for the group that attended the education program.   
 This project did not meet the goal education attendance rate of 62.5%.  The proportion of 
attendees was found to be significantly different from the goal of 62.5%.  Communication with 
patients was a barrier in the link to the education program for the clinic and the DSMES 
program.  Forty-three percent of participants who did not attend the education program were left 
voicemails multiple times, but never responded, eventually resulting in a “send-back” to the 
provider.  Forty-three percent answered, but declined the education program when contacted 
about attending.  The final 7% of the group that did not attend the education program did not 
show up to the initial scheduled education session.  In the future, an alternative method of 
contacting patients may be beneficial in increasing the attendance rate.   
 There was a significant decrease in one participant’s HbA1C level in the group that did 
not attend the education program (33% decrease from pre-HbA1C level).  It was noted that this 
participant initiated subcutaneous injections in their diabetes treatment plan at the time of referral 
to the diabetes education program, which could have had an effect on post-referral HbA1C levels 
in the group that did not attend the DSMES program.   
 Project duration could have limited the results of the study.  A few participants were due 
for follow-up at the time of data collection, so they could have completed their lab work shortly 
after data collection took place.  Project implementation took place during winter months, with 
data collection taking place just after the beginning of the new year.  Since many people indulge 
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in carbohydrate-rich foods during this time and may defer follow-ups due to holiday obligations, 
a longer project period may be beneficial. 
Strengths 
 This project used a technological modality to order diabetes education for participants.  
The National Diabetes Education Program, which was established in a partnership between the 
CDC and U.S. Department of Health and Human Services (HHS) National Institutes of Health 
(NIH) encourages self-management of diabetes that is sustainable and promotes technological 
advances to link patients, providers, and communities to strategies and support that encourage 
sustainable self-management (HHS, NIH, National Institute of Diabetes and Digestive and 
Kidney Diseases [NIDDK], 2014).   
Although no significant change was found in the pre- and post-referral means of HbA1C 
in patients that attended the group education program verses those that did not attend the 
education program, the participant who attended the program and completed lab work post-
education did demonstrate a decrease in the HbA1C level of 3.7%, which was a 33% decrease 
from the pre-referral HbA1C level.  
Although the project did not meet the national attendance goal, it did increase the number 
of patients at the clinic who attended a formal diabetes education program.  Since there was no 
referral process for diabetes education in place for the project site, this project created a link 
between the provider, the patients, and the DSMES program, which resulted in 30% of 
participants attending at least 1 hour of the DSMES program they were referred to. Twenty 
percent of participants attended all 10 hours of the DSMES program. 
Sustainability 
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 The EHR template was implemented for ordering DSMES to simplify the process for 
providers and staff, and to promote sustainability.   Providers will be able to use the template 
after program completion to create the link between patients and the DSMES program in the 
community.  The template could also be used for additional DSMES sites in the future.   
Implications for Practice 
Medicare and Medicaid, along with many other insurance plans, will cover up to 10 hours 
of DSMES the first year (Warshaw, 2018). However, even if a person does not participate in all 
10 hours, they may only receive coverage for up to two hours of education in the subsequent 
years.   Healthcare providers must take advantage of these 10 hours of available education for 
their patients in their first year after diagnosis to help them learn how to manage their diabetes by 
linking patients to these services and encouraging them to follow through with them.   
Insurance companies may require certain information to cover the services, so providers 
must make sure they are meeting all criteria when ordering educational services for patients with 
diabetes. Templates in the EHR can be used to remind providers of steps they should take with 
patients who have T2DM to address all significant areas of concern.  Templates can also be used 
to make sure the pertinent information is included in orders and referrals to promote 
reimbursement for provider services, including other services or support they may order for the 
patient.  To meet the demands of evolving reimbursement strategies and the increasing 
prevalence of patients with T2DM, providers will need to be more proactive, while utilizing the 
EHR’s specialized features, such as templates to reduce documentation load, to encourage 
ongoing support for patients with T2DM.  Providers will need to make more collaborative efforts 
to link patients to community resources to manage and support various aspects of those patients’ 
care.   
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The results of this project suggest that alternative modalities for communicating with 
patients may be beneficial, as communication via telephone was a barrier to contacting patients 
for the clinic and the DSMES program.  Subsequent studies could use other means of 
communication, such as text messages, e-mails, or cellular phone applications to coordinate care 
with patients.  Finding a reliable means of communication will be essential.  Since 70% of 
participants did not complete the recommended post-referral HbA1C, they may not be receiving 
optimal care for their T2DM, and successful alternatives for reminding these patients to follow 
up would benefit patients and providers.  
Conclusion 
 Although comparisons of pre-referral and post-referral means of participants who 
attended DSMES and participants who did not attend DSMES were not significant, using 
imputed data for missing values, there was a decrease in post-referral HbA1C in the participant 
who attended DSMES and completed recommended post-referral HbA1C lab work.  Patients 
may not be following up with lab work or providers for optimal treatment of their T2DM.  
Implementing an EHR template and training staff to use the template can streamline the ordering 
process for DSMES and increase the attendance of formal diabetes education in patients, but 
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Year 2017 2015 2013 2017 2014 2014 2017 2018 2015 2017 
LOE I II II II IV II IV II III II 
Design review CCT RCT RCT PBC RCT SCRI CRCT CLPS RCT 
T2DM 
only 
yes yes yes yes T1DM 
included 
yes yes yes yes yes 
Attrition N/A 0% 8.2% 0% 21% 12% 28% 27% 32% 45% 
# of 
Participants 
8,533 193 681 238 77,824 2,378 82 341 150 157 
Country Assorted Greece Germany/ 
Spain 
Brazil Canada U. S. Brazil Brazil Brazil U.S.  
(Arizona) 
Intervention GBE GBE GBE IBE, 
ME, 
GBE 





















































GBE effect on 
KOD 
 N/A  N/A N/A N/A  N/A  N/A 
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GBE effect on 
HbA1C 
    N/A NSE   N/A NSE 
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Appendix C 
 Figure 1 
 
Reprinted with permission from ACP-ASIM Journals and Books (Wagner, 1998)





(Dawson & Andriopoulos, 2017)




 Activities Cost 
Design and print pamphlets for 
education program (200) 
$40 
Design & print educational 
materials for staff meeting 
$2 
Related physician loss of 
productivity for staff meeting cost 
$160 
Related staff loss of productivity 
for staff meeting cost 
$14.85 
Food items for staff meeting $25 
Locking box and files for patient 
paper files related to project 
$60 
 
TOTAL 
 
$301.85 
